Free-cash-flow proxy increased 43.5%
Free-cash-flow proxy changed +43.5% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
-$71.8M→-$40.6M2 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →BCYC financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Operating income increased 79.4%
Operating income changed +79.4% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
-$65.6M→-$13.5M2 prior comparisons
Operating cash flow increased 43.4%
Operating cash flow changed +43.4% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
-$71.2M→-$40.3M2 prior comparisons
Current liabilities decreased 35.8%
Current liabilities changed -35.8% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
$69.3M→$44.5M4 prior comparisons
Operating margin moved 51907 bp higher
Operating margin changed +51907 basis points from the comparable as-filed period.
-558.64%→-39.57%2 prior comparisons
Revenue increased 190.2%
Revenue changed +190.2% from the comparable as-filed period.
$11.7M→$34.1M2 prior comparisons
Research & development decreased 42.8%
Research & development changed -42.8% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$58.4M→$33.4M2 prior comparisons
Capex / revenue moved 485 bp lower
Capex / revenue changed -485 basis points from the comparable as-filed period.
5.74%→0.90%2 prior comparisons
Stock-based compensation decreased 38.2%
Stock-based compensation changed -38.2% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$8.8M→$5.4M2 prior comparisons
Cash & equivalents decreased 27.5%
Cash & equivalents changed -27.5% from the comparable as-filed period.
$648.3M→$469.9M2 prior comparisons
SBC / revenue moved 5884 bp lower
SBC / revenue changed -5884 basis points from the comparable as-filed period.
74.75%→15.91%2 prior comparisons
Current assets decreased 27.2%
Current assets changed -27.2% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
$738.8M→$537.6M4 prior comparisons
Working capital decreased 26.4%
Working capital changed -26.4% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$669.5M→$493.1M4 prior comparisons
Total assets decreased 25.8%
Total assets changed -25.8% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
$764.0M→$567.2M4 prior comparisons
R&D / revenue moved 39979 bp lower
R&D / revenue changed -39979 basis points from the comparable as-filed period.
497.92%→98.14%2 prior comparisons
Capital expenditure decreased 54.7%
Capital expenditure changed -54.7% from the comparable as-filed period.
$674,000→$305,0002 prior comparisons
Operating cash-flow margin moved 48822 bp higher
Operating cash-flow margin changed +48822 basis points from the comparable as-filed period.
-606.55%→-118.34%2 prior comparisons
Free-cash-flow margin moved 49307 bp higher
Free-cash-flow margin changed +49307 basis points from the comparable as-filed period.
-612.30%→-119.23%2 prior comparisons
Current ratio increased 13.4%
Current ratio changed +13.4% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
10.66→12.094 prior comparisons
Working capital / assets moved 70 bp lower
Working capital / assets changed -70 basis points from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
87.64%→86.94%4 prior comparisons
Current liabilities decreased 38.5%
Current liabilities changed -38.5% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
$77.4M→$47.6M4 prior comparisons
Operating income increased 37.0%
Operating income changed +37.0% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
-$86.6M→-$54.6M2 prior comparisons
Operating margin moved 570810 bp lower
Operating margin changed -570810 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
-2965.82%→-8673.93%2 prior comparisons
Free-cash-flow proxy increased 31.9%
Free-cash-flow proxy changed +31.9% from the comparable as-filed period.
-$73.3M→-$49.9M3 prior comparisons
Operating cash flow increased 31.8%
Operating cash flow changed +31.8% from the comparable as-filed period.
-$72.8M→-$49.6M3 prior comparisons
Revenue decreased 78.5%
Revenue changed -78.5% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$2.9M→$629,0002 prior comparisons
Research & development decreased 42.1%
Research & development changed -42.1% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$71.0M→$41.2M2 prior comparisons
Stock-based compensation decreased 32.1%
Stock-based compensation changed -32.1% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$9.4M→$6.4M2 prior comparisons
Capital expenditure decreased 46.8%
Capital expenditure changed -46.8% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$498,000→$265,0003 prior comparisons
Capex / revenue moved 2508 bp higher
Capex / revenue changed +2508 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
17.05%→42.13%2 prior comparisons
Cash & equivalents decreased 29.3%
Cash & equivalents changed -29.3% from the comparable as-filed period.
$721.5M→$510.1M2 prior comparisons
SBC / revenue moved 69501 bp higher
SBC / revenue changed +69501 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
323.12%→1018.12%2 prior comparisons
Current assets decreased 28.5%
Current assets changed -28.5% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$804.3M→$575.2M4 prior comparisons
Working capital decreased 27.4%
Working capital changed -27.4% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
$726.8M→$527.6M4 prior comparisons
Total assets decreased 27.1%
Total assets changed -27.1% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$832.2M→$606.6M4 prior comparisons
R&D / revenue moved 411122 bp higher
R&D / revenue changed +411122 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
2432.50%→6543.72%2 prior comparisons
Free-cash-flow margin moved 541889 bp lower
Free-cash-flow margin changed -541889 basis points from the comparable as-filed period.
-2509.73%→-7928.62%2 prior comparisons
Operating cash-flow margin moved 539382 bp lower
Operating cash-flow margin changed -539382 basis points from the comparable as-filed period.
-2492.67%→-7886.49%2 prior comparisons
Current ratio increased 16.2%
Current ratio changed +16.2% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
10.39→12.084 prior comparisons
Working capital / assets moved 36 bp lower
Working capital / assets changed -36 basis points from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
87.34%→86.98%4 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.